To identify the mechanisms of viral persistence in coincides with the cessation of hepatocyte injury. 1,2 Howpatients with chronic hepatitis B after the acquisition ever, with current molecular biological techniques, trace of anti -hepatitis B surface antigen antibodies (anticoncentrations of HBV DN
Analysis of hepatitis B surface antigen mutations in Mongolia: Molecular epidemiology and implications for mass vaccination
β Scribed by D. Davaalkham; T. Ojima; R. Uehara; M. Watanabe; I. Oki; K. Endo; M. Takahashi; H. Okamoto; Y. Nakamura
- Book ID
- 106210741
- Publisher
- Springer Vienna
- Year
- 2006
- Tongue
- English
- Weight
- 404 KB
- Volume
- 152
- Category
- Article
- ISSN
- 1432-8798
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Of 1,801 Chinese subjects, age 1 to 90 years, screened for hepatitis B surface antigen and antibody (HBsAg, anti-HBs) and antibody to hepatitis B core antigen (anti-HBc), 214 (1 1.9%) had an isolated, positive anti-HBc result; anti-HBc was reproducibly present in the initial sera in only 66% and per
Hepatitis B surface antigen (HBsAg) and anti-HBs antibodies (anti-HBs) may coexist in certain chronic hepatitis B (CHB) patients. This study was designed to further explore the relationship between this coexistence and hepatitis B Virus (HBV) preS deletions. Sera of 28 patients carrying both HBsAg a
## Abstract Escape mutations in the major hydrophilic region (MHR) of hepatitis B surface antigen (HBsAg) are reported widely worldwide; these mutations lead to diagnostic problems, emergence of vaccineβescape mutants, and hepatitis B immunoglobulin (HBIG) therapy failure. However, the prevalence o